Neurogenesis in aging and age-related neurodegenerative diseases.

Abstract

Adult neurogenesis, the process by which neurons are generated in certain areas of the adult brain, declines in an age-dependent manner and is one potential target for extending cognitive healthspan. Aging is a major risk factor for neurodegenerative diseases and, as lifespans are increasing, these health challenges are becoming more prevalent. An age-associated loss in neural stem cell number and/or activity could cause this decline in brain function, so interventions that reverse aging in stem cells might increase the human cognitive healthspan. In this review, we describe the involvement of adult neurogenesis in neurodegenerative diseases and address the molecular mechanistic aspects of neurogenesis that involve some of the key aggregation-prone proteins in the brain (i.e., tau, Aβ, α-synuclein, …). We summarize the research pertaining to interventions that increase neurogenesis and regulate known targets in aging research, such as mTOR and sirtuins. Lastly, we share our outlook on restoring the levels of neurogenesis to physiological levels in elderly individuals and those with neurodegeneration. We suggest that modulating neurogenesis represents a potential target for interventions that could help in the fight against neurodegeneration and cognitive decline.

• Authors: Luka Culig, Xixia Chu, Vilhelm A Bohr
• Journal: Ageing research reviews (Ageing Res Rev) Vol. 78 Pg. 101636 (06 2022) ISSN: 1872-9649 [Electronic] England
• PMID: 35490966 (Publication Type: Journal Article, Review, Research Support, N.I.H., Intramural)
• Copyright: Published by Elsevier B.V.

Topics

• Aged
• Aging (physiology)
• Hippocampus (metabolism)
• Humans
• Neural Stem Cells (physiology)
• Neurodegenerative Diseases (metabolism)
• Neurogenesis (physiology)